I am...
- All
- ECD
- HLH/FEL/FHL
- JXG
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Innate T cells in Langerhan’s Cell Histiocytosis
Principal Investigator Stuart Berzins, Ph.D. Federation University Australia Ballarat, Victoria, Australia Date of Award December 2016 Amount…
The Interplay of NOTCH and MAPK Pathway in LCH
Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria Date of Award December…
LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions
Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA Date of Award…
Novel Animal Model for LCH
Principal Investigator Sergio Lira, MD, PhD Icahn School of Medicine at Mount Sinai, New York, New York…
Exploring CD8+ T cell-LCH-cell Interactions in Langerhans cell histiocytosis: A Three Center Study
Principal Investigator Astrid van Halteren, PhD Leiden University Medical Center, Leiden, Netherlands Date of Award December 2014…
Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High-Risk LCH
Principal Investigator Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai – New York, New…
Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study
Project Administrators Histiocyte Society Executive Board LCH Study Reference Center – Vienna, Austria Date of Award December…
Dysregulation of Dendritic Cell Development in Langerhans Cell Histiocytosis
Principal Investigator Matthew Collin, MD Newcastle University – Newcastle upon Tyne, United Kingdom Date of Award December…
Whole Exome Sequencing of Langerhans Cell Histiocytosis
Principal Investigator and Co-Investigator Barrett Rollins MD, PhD (PI) Dana-Farber Cancer Institute – Boston, Massachusetts USA Astrid…
Research Infrastructure for Clinical and Translational Research in Langerhans Cell Histiocytosis (LCH)
Principal Investigator Carlos Rodriguez-Galindo MD Dana-Farber Cancer Institute – Boston, Massachusetts USA Date of Award December 2012…